'One medicine - One pathology': Are veterinary and human pathology prepared?

Laboratory Investigation

Volumn 88, Issue 1, 2008, Pages 18-26

  Cardiff, Robert D ^a,b   Ward, Jerrold M ^c   Barthold, Stephen W ^a,b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Comparative pathology; Education; Genomic biology; Genomic pathology; One medicine

Indexed keywords

COMPARATIVE STUDY; EDUCATION; GENERAL PATHOLOGY; GENOMICS; HISTORY OF MEDICINE; HUMAN; MICROSCOPY; MOLECULAR BIOLOGY; NONHUMAN; ORGANIZATION; PATHOLOGIST; PHYSICIAN; PRIORITY JOURNAL; REVIEW; SPECIES COMPARISON; VETERINARY MEDICINE;

EID: 37549036339     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.3700695     Document Type: Review

References (82)

1. Rosati LA. The microbe, creator of the pathologist: an inter-related history of pathology, microbiology, and infectious disease. Ann Diagn Pathol 2001;5:184-189.
2. Saunders LZ. Virchow's contributions to veterinary medicine: celebrated then, forgotten now. Vet Pathol 2000;37:199-207.
3. Mould RF. More of Mould's Medical Anecdotes (pg 179). Adam Hifger: Bristol, 1989, pp 269.
4. Sidel VW. Introduction. In: Link EP (ed). The Social Ideas of American Physicians (1776-1976): Studies of the Humanitarian Tradition in Medicine. Susquehanna University Press: Selinsgrove, PA, USA, 1992, pp 23-27.
5. Thudichum. The trichina disease. Edinburgh Med J 1866;XI(Part II):771-772.
6. Dukes TW. The other branch of medicine: an historiography of veterinary medicine from a Canadian perspective. Can Bull Med Hist 2000;17:229-243.
7. Saunders LZ. From Osler to Olafson. The evolution of veterinary pathology in North America. Can J Vet Res 1987;51:1-26.
8. Teigen PM. William Osler and comparative medicine. Can Vet J 1984;25:400-405.
9. Cardiff RD, Kenney N. Mouse mammary tumor biology: a short history. Adv Cancer Res 2007;98:53-116.
10. Dolman CE, Wolf RJ. Suppressing the Diseases of Animals and Man: Theobald Smith, Microbiologist. Harvard University Press: Cambridge, 2003.
11. Zinsser H. Biographical Memoir of Theobald Smith 1859-1934. In: National Academy of Science Biographical Memoirs. National Academy Press: Washington, DC, 1936, pp 261-303.
12. Schwabe CW. Veterinary Medicine and Human Health, 3rd edn. Williams & Wilkins: Baltimore, 1984, xix, pp 1-680.
13. Schwabe CW. Veterinary Medicine and Human Health. Williams & Wilkins: Baltimore, 1964, xvii, pp 1-516.
14. Schwabe CW. Veterinary Medicine and Human Health, 2nd edn. Williams & Wilkins: Baltimore, 1969, xx, pp 1-713.
15. Committee on Increasing Veterinarian Involvement in Medical Research. National Need and Priorities for Veterinarians in Biomedical Research. National Academies Press: Washington, DC, 2004, p 87.
16. Committee on the National Needs for Research in Veterinary Science. In: National Research Council of the National Academies (ed). Committee on the National Needs for Research in Veterinary Science. Critical Needs for Research in Veterinary Science. National Academies Press: Washington, DC, 2005, p 222.
17. Kass ME, Crawford JM, Bennett B, et al. Adequacy of pathology resident training for employment: a survey report from the Future of Pathology Task Group. Arch Pathol Lab Med 2007;131:545-555.
18. Kahn LH. Confronting zoonoses, linking human and veterinary medicine. Emerg Infect Dis 2006;12:556-561.
19. Enserink M. Medicine. Initiative aims to merge animal and human health science to benefit both. Science (New York, NY) 2007;316:1553.
20. Nolen RS. One-health movement gaining momentum: Stronger Ties Sought Between Veterinarians, Physicians. 14th AVMA Convention Daily News 2007.
21. Hilty M, Diguimbaye C, Schelling E, et al. Evaluation of the discriminatory power of variable number tandem repeat (VNTR) typing of Mycobacterium bovis strains. Vet Microbiol 2005;109:217-222.
22. Zinsstag J, Schelling E, Wyss K, et al. Potential of cooperation between human and animal health to strengthen health systems. Lancet 2005;366:2142-2145.
23. Zinsstag J, Weiss MG. Livestock diseases and human health. Science (New York, NY) 2001;294:477.
24. Peters LL, Robledo RF, Bult CJ, et al. The mouse as a model for human biology: a resource guide for complex trait analysis. Nat Rev Genet 2007;8:58-69.
25. Paigen K. A miracle enough: the power of mice. Nat Med 1995;1:215-220.
26. Sattler M, Scheijen B, Weisberg E, et al. Mutated tyrosine kinases as therapeutic targets in myeloid leukemias. Adv Exp Med Biol 2003;532:121-140.
27. Rego EM, Ruggero D, Tribioli C, et al. Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha. Oncogene 2006;25:1974-1979.
28. Herschkowitz JI, Simin K, Weigman VJ, et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 2007;8:R76.
29. Maser RS, Choudhury B, Campbell PJ, et al. Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers. Nature 2007;447:966-971.
30. Tomlins SA, Chinnaiyan AM. Of mice and men: cancer gene discovery using comparative oncogenomics. Cancer cell 2006;10:2-4.
31. Peeper D, Berns A. Cross-species oncogenomics in cancer gene identification. Cell 2006;125:1230-1233.
32. Daley GQ. Animal models of BCR/ABL-induced leukemias. Leuk Lymphoma 1993;11(Suppl 1):57-60.
33. Begemann M, Fuller GN, Holland EC. Genetic modeling of glioma formation in mice. Brain Pathol (Zurich, Switzerland) 2002;12:117-132.
34. Barthold SW. 'Muromics': genomics from the perspective of the laboratory mouse. Comp Med 2002;52:206-223.
35. Cardiff RD. Pathologists needed to cope with mutant mice. Nature 2007;447:528.
36. Barthold SW, Borowsky AD, Brayton C, et al. From whence will they come? A perspective on the acute shortage of pathologists in biomedical research. J Vet Diagn Invest 2007;19:455-456.
37. Cardiff RD, Munn RJ, Galvez JJ. The tumor pathology of genetically engineered mice: a new approach to molecular pathology. In: Fox JG, Davisson MT, Quimby FW, Barthold SW, Newcomer CE, Smith AL (eds). The Mouse in Biomedical Research: Experimental Biology and Oncology, Vol. 2, 2nd edn. Elsevier Inc.: New York, 2006, pp 581-622.
38. Fox JG. The Mouse in Biomedical Research, 2nd edn. Elsevier: Amsterdam, Boston, 2007.
39. Holland EC. Mouse Models of Human Cancer. John Wiley & Sons: Hoboken NJ, 2004, xi, 474pp.
40. Mahler JF, Stokes W, Mann PC, et al. Spontaneous lesions in aging FVB/N mice. Toxicol Pathol 1996;24:710-716.
41. Maronpot RR, Boorman GA, Gaul BW. Pathology of the Mouse: Reference and Atlas, 1st edn. Cache River Press: Vienna, IL, 1999, 699pp.
42. Percy DH, Barthold SW. Pathology of Laboratory Rodents and Rabbits, 3rd edn. Blackwell Pub. Professional: Ames, Iowa, 2007.
43. Ward JM. Pathology of Genetically Engineered Mice, 1st edn. Iowa State University Press: Ames, 2000, p xi, 394pp.
44. Barthold SW. Genetically altered mice: phenotypes, no phenotypes, and Faux phenotypes. Genetica 2004;122:75-88.
45. Ward JM, Sundberg J. Preventing publication errors: the need for a pathologist in the evaluation of genetically engineered mice. Vet Pathol 2004;41:562.
46. Percy DH, Barthold SW. Pathology of Laboratory Rodents and Rabbits, 3rd edn. Blackwell Publishing: Ames, Iowa, 2007, 325pp.
47. Fu L, Pelicano H, Liu J, et al. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 2002;111:41-50.
48. Nakamura Y, Fukami K, Yu H, et al. Phospholipase Cdelta1 is required for skin stem cell lineage commitment. EMBO J 2003;22:2981-2991.
49. Rosbash M, Takahashi JS. Circadian rhythms: the cancer connection. Nature 2002;420:373-374.
50. Coste I, Freund JN, Spaderna S, et al. Precancerous lesions upon sporadic activation of beta-catenin in mice. Gastroenterology 2007;132:1299-1308.
51. Cardiff RD, Anver MR, Boivin GP, et al. Precancer in mice: animal models used to understand, prevent, and treat human precancers. Toxicol Pathol 2006;34:699-707.
52. Kullberg MC, Ward JM, Gorelick PL, et al. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect Immun 1998;66:5157-5166.
53. Berg DJ, Davidson N, Kuhn R, et al. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest 1996;98:1010-1020.
54. Boivin GP, Washington K, Yang K, et al. Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology 2003;124:762-777.
55. Barthold SW. Intercurrent infections in genetically engineered mice. In: Holland E (ed). Mouse Models of Human Cancer. John Wiley & Sons: Hoboken, NJ, 2004, pp 31-41.
56. Engle SJ, Hoying JB, Boivin GP, et al. Transforming growth factor beta1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis. Cancer Res 1999;59:3379-3386.
57. Engle SJ, Ormsby I, Pawlowski S, et al. Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice. Cancer Res 2002;62:6362-6366.
58. Muller WJ, Sinn E, Pattengale PK, et al. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 1988;54:105-115.
59. Maglione JE, Moghanaki D, Young LJ, et al. Transgenic Polyoma middle-T mice model premalignant mammary disease. Cancer Res 2001;61:8298-8305.
60. Rudolph KL, Chang S, Lee HW, et al. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 1999;96:701-712.
61. Schriner SE, Linford NJ, Martin GM, et al. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science (New York, NY) 2005;308:1909-1911.
62. Yan L, Vatner DE, O'Connor JP, et al. Type 5 adenylyl cyclase disruption increases longevity and protects against stress. Cell 2007;130:247-258.
63. Vasquez SX, Bahadur AN, Johnson JT, et al. Severe runting in a laboratory mouse (Mus musculus). Lab Anim 2007;36, 19, 22-23.
64. Brayton C, Justice M, Montgomery CA. Evaluating mutant mice: anatomic pathology. Vet Pathol 2001;38:1-19.
65. Ruggero D, Grisendi S, Piazza F, et al. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science (New York, NY) 2003;299:259-262.
66. Cardiff RD, Rosner A, Hogarth MA, et al. Validation: the new challenge for pathology. Toxicol Pathol 2004;32(Suppl 1):31-39.
67. Shappell SB, Thomas GV, Roberts RL, et al. Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the mouse models of human cancer consortium prostate pathology committee. Cancer Res 2004;64:2270-2305.
68. Morse III HC, Anver MR, Fredrickson TN, et al. Bethesda proposals for classification of lymphoid neoplasms in mice. Blood 2002;100:246-258.
69. Weiss WA, Israel M, Cobbs C, et al. Neuropathology of genetically engineered mice: consensus report and recommendations from an international forum. Oncogene 2002;21:7453-7463.
70. Cardiff RD, Anver MR, Gusterson BA, et al. The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene 2000;19:968-988.
71. Nikitin AY, Alcaraz A, Anver MR, et al. Classification of proliferative pulmonary lesions of the mouse: recommendations of the mouse models of human cancers consortium. Cancer Res 2004;64:2307-2316.
72. Park JH, Walls JE, Galvez JJ, et al. Prostatic intraepithelial neoplasia in genetically engineered mice. Am J Pathol 2002;161:727-735.
73. Cardiff RD, Moghanaki D, Jensen RA. Genetically engineered mouse models of mammary intraepithelial neoplasia. J Mammary Gland Biol Neoplasia 2000;5:421-437.
74. Austsin CP. The knock out mouse project. Nat Genet 2004;36:921-924.
75. Mutant mice galore. Nature 2007;446:469-470.
76. Cardiff RD, Sinn E, Muller W, et al. Transgenic oncogene mice. Tumor phenotype predicts genotype. Am J Pathol 1991;139:495-501.
77. Rosner A, Miyoshi K, Landesman-Bollag E, et al. Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors. Am J Pathol 2002;161:1087-1097.
78. Kogan SC, Ward JM, Anver MR, et al. Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. Blood 2002;100:238-245.
79. Sundberg JP, Hackman RC, HogenEsch H, et al. Training mouse pathologists: five years of pathology of mouse models of human disease workshops. Toxicol Pathol 2007;35:447-448.
80. Barthold SW. Biomedical research and veterinarians: where's Waldo? Comp Med 2002;52:95-96.
81. Barthold SW. Musings of a Connecticut Yankee in King Arthur's court: antemortem analysis of the veterinary profession. J Vet Med Edu 2005;32:306-313.
82. Rosai J. Why microscopy will remain a cornerstone of surgical pathology. Lab Invest 2007;87:403-408.